GetTopicDetailResponse(id=b8ff69015d, topicName=Eptinezumab單抗, introduction=Eptinezumab單抗, content=null, image=null, comments=1, allHits=639, url=https://h5.medsci.cn/topic?id=6901, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102025, tagList=[TagDto(tagId=102025, tagName=Eptinezumab單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1785756, encodeId=9c921e85756e4, content=<a href='/topic/show?id=b8ff69015d' target=_blank style='color:#2F92EE;'>#Eptinezumab單抗#</a>, objectTitle=Neurology：Eptinezumab單抗治療慢性偏頭痛的療效和安全性, objectType=article, longId=190816, objectId=2cd21908167c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cd21908167c, replyNumber=0, likeNumber=99, createdTime=2020-11-06, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cd21908167c, moduleTitle=Neurology：Eptinezumab單抗治療慢性偏頭痛的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2cd21908167c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
